Verapamil COER-24 180/240mg na hipertensäo arterial leve a moderada em dose única diária avaliado pela monitorizaçäo ambulatorial da pressäo arterial / Single daily dose of verapamil (COER-24 180/24 mg) in mild and moderate hypertension evaluated by ambulatory blood pressure monitoring
Arq. bras. cardiol
; Arq. bras. cardiol;74(3): 283-90, mar. 2000. tab, graf
Article
em Pt
| LILACS
| ID: lil-265169
Biblioteca responsável:
BR1.1
RESUMO
OBJECTIVE:
To evaluate the anti-hypertensive effecft of verapamil COER-24 180/240 mg in a single dose at bedtime as single therapy in mild to moderate hypertensives.METHODS:
A multicentric, open, placebo controlled study of 81 hypertensive patients older than 20 years-old followed to 8 weeks. Blood pressure was measured in doctor's office and by 24h ambulatory monitoring (ABPM).RESULTS:
We observed a decreased in systolic and diastolic blood pressure in doctor's office at 4th and 8th weeks. ABPM showed that both systolic, diastolic and mean blood pressure, heart rate and the mean 24-hour blood pressure load decreased after the 8-week treatment. In addition, there was a reduction of the double-product, especially in the morning and 68 per cent of the patients didn't have any adverse events.CONCLUSION:
The theraphy verapamil COER-24 180/240mg in a single dose is useful for mild and moderate hypertensive patients, with significant pressure decrease in both office blood pressure measurements and in the ABPM/24 hours, as well as showing good tolerability.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Bloqueadores dos Canais de Cálcio
/
Verapamil
/
Monitorização Ambulatorial da Pressão Arterial
/
Hipertensão
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
Pt
Revista:
Arq. bras. cardiol
Assunto da revista:
CARDIOLOGIA
Ano de publicação:
2000
Tipo de documento:
Article
País de publicação:
Brasil